Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
6.69
-0.05 (-0.74%)
At close: Mar 27, 2026
Coloplast Revenue
Coloplast had revenue of 7.04B DKK in the quarter ending December 31, 2025, with 0.24% growth. This brings the company's revenue in the last twelve months to 27.89B, up 1.61% year-over-year. In the fiscal year ending September 30, 2025, Coloplast had annual revenue of 27.87B with 3.12% growth.
Revenue (ttm)
27.89B DKK
Revenue Growth
+1.61%
P/S Ratio
3.41
Revenue / Employee
1.64M DKK
Employees
16,983
Market Cap
14.93B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 27.87B | 844.00M | 3.12% |
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | 17.94B | 1.49B | 9.06% |
| Sep 30, 2018 | 16.45B | 921.00M | 5.93% |
| Sep 30, 2017 | 15.53B | 847.00M | 5.77% |
| Sep 30, 2016 | 14.68B | 772.00M | 5.55% |
| Sep 30, 2015 | 13.91B | 1.48B | 11.92% |
| Sep 30, 2014 | 12.43B | 793.00M | 6.82% |
| Sep 30, 2013 | 11.64B | 612.00M | 5.55% |
| Sep 30, 2012 | 11.02B | 851.00M | 8.37% |
| Sep 30, 2011 | 10.17B | 635.00M | 6.66% |
| Sep 30, 2010 | 9.54B | 717.00M | 8.13% |
| Sep 30, 2009 | 8.82B | 357.00M | 4.22% |
| Sep 30, 2008 | 8.46B | 421.00M | 5.24% |
| Sep 30, 2007 | 8.04B | 1.33B | 19.87% |
| Sep 30, 2006 | 6.71B | 477.00M | 7.65% |
| Sep 30, 2005 | 6.23B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Standard Dental Labs | 306.82K |
| Hear AtLast Holdings | 93.20K |
| Cardiac Biotech Solutions | 50.37K |
| Yubo International Biotech | -18.00 |
Coloplast News
- 12 days ago - Coloplast: The Market Is Throwing Away A High-Quality Compounder - Seeking Alpha
- 17 days ago - Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons - GlobeNewsWire
- 18 days ago - Coloplast A/S - Allocation of Share Options - GlobeNewsWire
- 24 days ago - Coloplast appoints Gavin Wood as new CEO - GlobeNewsWire
- 6 weeks ago - Coloplast A/S - Updated Financial Calendar 2025-26 - GlobeNewsWire
- 7 weeks ago - Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Coloplast A/S - Interim Financial Report, Q1 2025/26 - GlobeNewsWire
- 3 months ago - Coloplast announces changes to Executive Leadership Team - GlobeNewsWire